ArticleClinical and experimental immunology2018

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.

J Lohmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.